BAT Launches Virtual R&D Visitor Experience

Apr.07.2022
BAT Launches Virtual R&D Visitor Experience
BAT launches virtual visitor experience showcasing cutting-edge research and development activities in various scientific fields.

January 19, 2022

 

BAT has launched a new virtual visitor experience that allows guests to "walk through" the company's research and development laboratories, meet top scientists, and view the results of new research. Tourists have the opportunity to explore the company's scientific methods and progress in reducing tobacco harm, as well as showcasing R&D activities in important and emerging fields such as biology, chemistry, toxicology, sensory science, aerosol analysis, product safety, consumer insights, and plant biotechnology. This underscores BAT's commitment to science in reducing the impact of its business on health and providing a better tomorrow. TMBAT has created a virtual R&D visitor experience, an online tour of its global R&D center located in Southampton, UK, allowing people to explore its cutting-edge science and innovation.

 

Experience is built on a foundation of the best available technology, open and transparent scientific methods, which support the reduction of risk in product portfolios and beyond nicotine activities. The company regularly welcomes visitors to its global research center, with over 3,500 people seeing the facilities firsthand since 2011. However, with travel greatly reduced, virtual experiences allow people from around the world to access and understand BAT's scientific research, reduce tobacco harm reduction (THR) activities, and gain insights and perspectives from experts.

 

David O'Reilly, PhD, the Director of scientific research at BAT, emphasized the importance of research and development as the foundation of their work. By prioritizing science and research, they have made significant progress in developing new product categories that have undergone rigorous testing and scientific validation as reduced-risk alternatives to traditional tobacco products. Their research is heavily influenced by consumer preferences and continually incorporates evolving scientific and innovative developments into their products. This approach allows them to offer a range of enjoyable, reduced-risk alternatives to cigarettes while maintaining very high safety and quality standards.

 

Our new virtual visitor experience showcases the breadth of science we are conducting and the strong scientific framework we are using to evaluate and support our products in reducing tobacco harm.

 

A virtual visitor experience has been developed, offering a one-stop center for people who wish to learn about the science behind BAT. This includes a tour through the 360-degree lab, animations, videos, scientist profiles and podcasts. The aim of this initiative is to highlight BAT's commitment in building a better future while reducing its impact on public health. BAT invests nearly £350 million annually to find innovative ways to reduce its influence on public health and aims to have 50 million non-combustible product consumers by 2030.

 

BAT conducts research in a wide range of scientific fields including molecular biology, toxicology, and chemistry, driving constant innovation and learning, and establishing the company as an industry leader.

 

Visitors who take a tour of the research and development virtual experience will be able to explore:

 

Sensory Science: This specialized department helps BAT better understand consumer product experiences and decodes them into actionable insights to support product and brand development. Biotech Laboratory: BAT scientists utilize their specialized knowledge in whole-genome sequencing, metabolomics, and computational biology to provide enhanced consumer experiences. These teams also grow plants and identify sustainable compound sources. Biology Laboratory: Scientists test BAT's new category products for potential impacts on human cells compared to cigarette smoke. Battery Laboratory: The facility revolutionizes the design, development, and testing of BAT's rechargeable devices. The batteries undergo rigorous speed tests to ensure they meet high-quality standards.

 

Original link:

 

British American Tobacco (BAT) has launched a virtual research and development visitor experience, showcasing world-class science behind their next-generation reduced-risk† nicotine products.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden is expected to oppose a European Union proposal to raise minimum tobacco excise duties, Law360 reported on October 26, 2026, citing an EU official. A provisional Council agenda dated October 23 confirms that the tobacco taxation package is scheduled for discussion at the November 9 finance ministers' meeting, where member states will seek a general approach. The proposed reforms would raise minimum taxes on conventional tobacco products and establish EU-wide excise rules for vaping liquids, heated tobacco and nicotine pouches. Sweden supports harmonising tobacco taxation rules but objects to requiring nicotine pouches to bear the same minimum tax burden as certain smoking tobacco products. As EU indirect tax legislation requires unanimous Council approval, Swedish opposition could block the proposal in its current form.
Regulations
Oct.29
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.
Regulations
Nov.11
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
China's Ministry of Finance and State Taxation Administration announced on October 12, 2026, that value-added tax (VAT) export rebates for vape devices, nicotine and its salts, and certain non-combustible inhalation products will be eliminated from April 1, 2027. The measure adds four tobacco- and nicotine-related customs codes, including 8543400010, which covers vape devices and qualifying empty pods. China previously eliminated rebates for nicotine-containing vaping products and devices under code 8543400090 in April 2026. According to industry classification information held by 2Firsts, the latter currently corresponds to heated tobacco devices. Export excise tax refund and exemption arrangements will remain unchanged.
Special Report
Oct.12
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08